Pinnacle Investment Management: Breaking new ground

About the author:

Scott Murdoch
Author name:
By Scott Murdoch
Job title:
Senior Analyst
Date posted:
05 August 2021, 1:30 PM
Sectors Covered:
Diversified Financials, Professional Services

  • Pinnacle Investment Management (ASX:PNI) reported group NPAT of A$67m, +107% on the pcp. Excluding Principal Investment and performance fee contribution, NPAT was +73% to A$45.2m.
  • Group FUM closed at A$89.4bn, up 52% on the pcp. The uplift was driven by net inflows (A$16.7bn) and investment performance (A$14.0bn).
  • Net inflow momentum accelerated in 2H21, with retail inflows of A$2.6bn (1H21: A$1.9bn). We expect strong flows at +A$8bn in FY22.
  • FY22 commences with starting FUM >20% above avg FY21 levels, supporting a ‘baseline’ earnings level (before performance fees) around FY21 levels.
  • PNI has material embedded growth and future optionality from acquisitions and moving offshore. However, the stock is now trading in-line with our valuation and we move to Hold.

Event: Big FY21 year

PNI reported NPAT of A$67m (+107% on pcp) and NPAT (ex PI and performance fees) of A$45.2m (+73% on pcp). The result beat expectations by ~3.5%.

PNI’s share of Affiliate profit was A$66.4m, up 74.7% on the pcp. Performance fees were ~30% of NPAT at A$19.5m (1H: A$11.1m; 2H: A$8.4m).

Of the seven disclosed Affiliate earnings, NPAT (100% basis) was: Hyperion +71% to A$42.4m; Resolution Capital +45% to A$21.4m; Solaris + 10% to A$14.6m; and Palisades +25% to A$12.4m. Metrics (A$13.1m), Coolabah (A$17.5m) and Firetrail (A$22m) earnings were disclosed for the first time.

PNI held cash and PI of A$96.1m and drawn debt of A$100m.

Analysis: Baseline earnings take a step-up

Near-term outlook: PNI enters FY22 with starting FUM +28% on average FY21, or ~23% excluding the A$3.9bn low-fee Plato mandate. Significant profit contributors, Hyperion and ResCap, commence with 20% and 34% higher FUM respectively. Excluding performance fees, we expect PNI’s base management fee earnings have sustainably stepped up and can sustain around the FY21 level into FY22.

 We expect the A$19.5m performance fee contribution will be difficult to hurdle in FY22, but see a reasonable range of A$10-18m as possible. Our forecasts imply a ~A$13m contribution from performance fees in FY22. FUM eligible for performance fees stands at A$28.7bn across 18 strategies.

Similarly, we expect net inflows to moderate however remain at very meaningful levels. We expect the primary FY21 contributors to flows were ResCap, Hyperion, Metrics and Coolabah and these groups are likely to repeat this in FY22. Our FY22 forecasts include A$8bn of net inflows. Medium term, scalable funds such as Hyperion Global have capability of drawing in significant FUM.

Investment outperformance is overall solid. Negative outliers include Solaris and Antipodes Global. Accelerated retail outflows in Antipodes poses a small risk.

Offshore expansion: PNI has previously signaled offshore expansion and stated offshore opportunities are becoming compelling. The inability to travel is impeding what we see as a probable offshore acquisition, however distribution and smaller ‘build’ opportunities are likely to feature nearer term.

Forecast and valuation update: Upgrades on higher FUM assumptions

We upgrade EPS by: FY22 4.4%; FY23 11.3%; and FY24 11.8%, which primarily reflects higher FUM levels.

Investment view: Move to a Hold recommendation

We believe PNI has significant further scale to be achieved within the current stable of managers and via further affiliates added (start up and acquisition). Successfully exporting the model offshore will also provide longevity to the growth profile. However, trading in range of our valuation (login to view price target), we move to a Hold recommendation.

Price Catalysts: Acquisitions

  • Acquisitions; significant flows/mandate wins; significant performance fees.


  • Heightened market volatility; sustained investment underperformance from a key manager; and lower than forecast performance fees.

Find out more

Download full research note

You can find further detailed analysis of company results this reporting season by browsing our reporting season tag, and view a full list of upcoming results on our Reporting Season Calendar.

If you would like access or more information, please contact your adviser or nearest Morgans office.

Request a call  Find local branch

Need access to our research?

You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team

Create trial account 

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

  • Print this page
  • Copy Link